One of the world’s largest cancer centers will collaborate with microbiome biotech Seres Therapeutics to investigate the gut microbiota’s role in shaping a patient’s response to immunotherapies. The MD Anderson Cancer Center and the Parker Institute for Cancer Immunotherapy signed the agreement with the Cambridge, Massachusetts–based biotech in November. Read more in Nature Biotechnology.
gut bacteria
Sewage Bacteria Reveal Cities’ Obesity Rates
Urban ‘microbiome’ can offer glimpses into disease trends. Sampling the waste in a city’s sewage system can be a good way to study the microbes that live in the population’s guts – and could even offer a way to monitor public health issues such as obesity, according to new research. The community of microbes that […]
Bacteria from lean mice prevents obesity in peers
But microbes are only part of the story — the effect also depends on a healthy diet. Gut bacteria from lean mice can invade the guts of obesity-prone cage-mates and help their new hosts to fight weight gain. Researchers led by Jeffrey Gordon, a biologist at Washington University in St. Louis, Missouri, set out to […]
Gut microbe may fight obesity and diabetes
Bacterium helps to regulate metabolism in mice. The gut is home to innumerable different bacteria — a complex ecosystem that has an active role in a variety of bodily functions. In a study published this week in Proceedings of the National Academy of Sciences, a team of researchers finds that in mice, just one of those […]